glp 1 parkinson's The glucagon-like peptide (GLP) receptor as a therapeutic target in disease: mechanisms of action GLP-1 Drugs and Parkinson's Disease:

Polysulfides are possible H 2 S-derived signaling molecules in rat brain

International journal of dermatology

When to Speak to Your GP About Period Changes on GLP-1 Whilst some menstrual changes may be expected during significant weight loss , certain symptoms warrant medical review to rule out other causes and ensure appropriate management

The GLP-1 RAs appear to modify atherosclerosis in the arteries, much like statin medications that treat cholesterol, and takes about a year or more to demonstrate measurable benefits on risk for cardiovascular events, whereas the SGLT2i medications seem to affect heart and kidney function more prominently and faster, with benefits evident very soon after starting the medication

doi: 10.1067/mpd.2000.106563 193 KhanMJGerasimidisKEdwardsCAShaikhMG

individual results will vary